Elequin Capital’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-41,545
Closed -$416K 940
2022
Q3
$416K Sell
41,545
-8,455
-17% -$84.1K 0.16% 65
2022
Q2
$495K Buy
+50,000
New +$494K 0.11% 57

Elequin Capital's LUXA Position: Q4 2022 in Review

Elequin Capital sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 41,545 shares — an estimated $416K sold.

Elequin Capital first reported a position in LUXA in Q2 2022 and held it in 2 quarters. The position peaked at $495K in Q2 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Elequin Capital reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Elequin Capital sold 41,545 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $416K.
  • Elequin Capital first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Elequin Capital's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $495K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.